Evidence map›Paper›PMID 39060833›Full record

ArticleAnnals of nuclear medicine2024

Prediction of 1 cm dose-equivalent rate on the day after administration of

Go Takai, Kohei Hanaoka, Keiji Nagano, Tsutomu Okada, Maya Honda, Izumi Komoto

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Pre-treatmentAnnals of nuclear medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Go TakaiDepartment of Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan. takai.go@b4.kepco.co.jp.
Kohei HanaokaDivision of Positron Emission Tomography, Institute of Advanced Clinical Medicine, Kindai University Hospital, 377-2 Ohno-Higashi, Osakasayama, Osaka, 589-8511, Japan.
Keiji NaganoDepartment of Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan.
Tsutomu OkadaDepartment of Diagnostic Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan.
Maya HondaDepartment of Diagnostic Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan.
Izumi KomotoDepartment of Surgery, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWhen patients administered

methodsWhole-body planar

resultsThe following relationships were observed between the radioactivity on

conclusionsThe amount of radioactivity accumulated on

Indexed as

Indium RadioisotopesOctreotideOrganometallic CompoundsReceptors, SomatostatinAdultAgedFemaleHumansMaleMiddle AgedRadiation DosageRadionuclide ImagingTime FactorsIndium-111Indium Radioisotopeslutetium Lu 177 dotatateOctreotideOrganometallic CompoundsReceptors, Somatostatin111In-somatostatine receptor scintigraphy177Lu-DOTATATE1 cm dose-equivalent ratePrediction factor

Identifiers

PMID39060833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.